OBJECTIVE: To present the long-term outcome after surgery for breast carcinoma in men. DESIGN: Retrospective study. SETTING: University Hospital, Switzerland. SUBJECTS: 37 consecutive men who were operated on for breast carcinoma between 1968 and 1998. RESULTS: The mean age was 67 years (range 41-89). The delay between the first clinical presentation and operation ranged from 1 month to 3 years (median 3.5 months). Operations included modified radical mastectomy (n = 19), radical mastectomy (n = 12), simple mastectomy (n = 3), Halsted procedure (n = 1), and conservative resection (n = 1). One patient had only a biopsy and was excluded from survival analysis. There were 30 infiltrating ductal carcinomas, 4 in situ ductal carcinomas, 2 papillary carcinomas, and 1 adenoid cystic carcinoma. Most tumors (n = 25, 68%) were in the subareolar region. The overall survival at 10 years was 44%, but it was significantly influenced by the stage of disease, ranging from 57% in stage I (n = 12), to 26% in stage II (n = 15), and 0 in stage III (n = 8). CONCLUSION: Although the long term survival in stage I and II is similar in men and women, the rarity of breast carcinoma in men and its location in the subareolar region may delay diagnosis and treatment.
OBJECTIVE: To present the long-term outcome after surgery for breast carcinoma in men. DESIGN: Retrospective study. SETTING: University Hospital, Switzerland. SUBJECTS: 37 consecutive men who were operated on for breast carcinoma between 1968 and 1998. RESULTS: The mean age was 67 years (range 41-89). The delay between the first clinical presentation and operation ranged from 1 month to 3 years (median 3.5 months). Operations included modified radical mastectomy (n = 19), radical mastectomy (n = 12), simple mastectomy (n = 3), Halsted procedure (n = 1), and conservative resection (n = 1). One patient had only a biopsy and was excluded from survival analysis. There were 30 infiltrating ductal carcinomas, 4 in situ ductal carcinomas, 2 papillary carcinomas, and 1 adenoid cystic carcinoma. Most tumors (n = 25, 68%) were in the subareolar region. The overall survival at 10 years was 44%, but it was significantly influenced by the stage of disease, ranging from 57% in stage I (n = 12), to 26% in stage II (n = 15), and 0 in stage III (n = 8). CONCLUSION: Although the long term survival in stage I and II is similar in men and women, the rarity of breast carcinoma in men and its location in the subareolar region may delay diagnosis and treatment.
Authors: A Salehi; H Zeraati; K Mohammad; M Mahmoudi; A R Talei; A Ghaderi; M H Imanieh; A Fotouhi Journal: Iran Red Crescent Med J Date: 2011-02-01 Impact factor: 0.611
Authors: Dharma Ram; Suhas K Rajappa; Veda P Selvakumar; Himanshu Shukla; Ashish Goel; Rajeev Kumar; Kapil Kumar Journal: South Asian J Cancer Date: 2017 Oct-Dec
Authors: Kaiyumars B Contractor; Kanchan Kaur; Gabriel S Rodrigues; Dhananjay M Kulkarni; Hemant Singhal Journal: World J Surg Oncol Date: 2008-06-16 Impact factor: 2.754